Insempra, a Munich, Germany-based biotechnology company raised $20M in funding.
Backers included EQT Ventures, BlueYard Capital, Possible Ventures, Taavet Sten, Acequia Capital Henkel dx Ventures, Bayern Kapital and Alante Capital.
The company intends to us the funds to continue building a technology platform that delivers high-performance, intrinsically sustainable ingredients for a wide range of industries, while supporting the scale up of its technology scouting, development, and manufacturing capabilities.
Led by CEO and Founder Jens Klein, Insempra is a biotechnology-powered company enabling businesses across beauty & personal care, food & nutrition, and fashion industries to transform their ingredient lists with products made in collaboration with nature.
Now, Insempra is growing lipids for cosmetic and food applications. It is also developing technology that offers a bio-based alternative to everyday materials such as polymers and textiles and progressing its biological solutions to create new natural molecules for use in functional ingredients, such as antioxidants and preservatives and flavours and fragrances.
Commenting on the news, Jens Klein said: “We are grateful for the support of this group of investors who have recognized the potential of Insempra’s market-first approach and innovative technology platforms. Working in collaboration with nature, we will continue to expand our capacity to develop intrinsically sustainable materials that are superior in quality and will reduce our dependency on chemical industrialization processes.”
FinSMEs
08/05/2024